Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Other Conditions
Vol. 2, Issue 1, 2014
August 06, 2014 EDT
Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence
Aaron Galaznik
,
Katherine Cappell
,
Leslie Montejano
,
Geoffrey Makinson
,
Kelly H. Zou
,
Gregory Lenhart
,
varenicline
utilization
smoking cessation
out-of-pocket
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9888
Photo by
A B E D K A Y A L I
on
Unsplash
JHEOR
1.
Galaznik A, Cappell K, Montejano L, Makinson G, Zou KH, Lenhart G. Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence.
JHEOR
. 2014;2(1):53-62.
doi:10.36469/9888
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats